Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

RedHill Biopharma (RDHL) Shares Outstanding (2017 - 2025)

RedHill Biopharma has reported Shares Outstanding over the past 9 years, most recently at $50.9 billion for Q4 2025.

  • Quarterly Shares Outstanding rose 294.76% to $50.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.9 billion through Dec 2025, up 294.76% year-over-year, with the annual reading at $50.9 billion for FY2025, 294.76% up from the prior year.
  • Shares Outstanding was $50.9 billion for Q4 2025 at RedHill Biopharma, up from $12.9 billion in the prior quarter.
  • Over five years, Shares Outstanding peaked at $50.9 billion in Q4 2025 and troughed at $526.8 million in Q4 2021.
  • The 5-year median for Shares Outstanding is $12.7 billion (2023), against an average of $15.7 billion.
  • Year-over-year, Shares Outstanding soared 980.5% in 2023 and then rose 1.2% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $526.8 million in 2021, then surged by 123.92% to $1.2 billion in 2022, then soared by 980.5% to $12.7 billion in 2023, then grew by 1.2% to $12.9 billion in 2024, then soared by 294.76% to $50.9 billion in 2025.
  • Per Business Quant, the three most recent readings for RDHL's Shares Outstanding are $50.9 billion (Q4 2025), $12.9 billion (Q4 2024), and $12.7 billion (Q4 2023).